Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (7) Birchmeier, Walter Prof. Dr. (11) Birchmeier-Kohler, Carmen Prof. Dr. (7) Dechend, Ralf Priv. Doz. (2) Falcke, Martin Prof. Dr. (1) Hübner, Norbert Prof. Dr. (6) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Jentsch, Thomas Prof. Dr. (9) Kettenmann, Helmut Prof. Dr. (17) Kettritz, Ralph Prof. Dr. (2) Kühn, Ralf Dr. (5) Lee, Young-Ae Prof. Dr. (2) Leutz, Achim Prof. Dr. (3) Lewin, Gary Prof. Dr. (1) Luft, Friedrich Prof. Dr. (29) Morano, Ingo Prof. Dr. (5) Müller, Dominik Prof. Dr. (1) Niendorf, Thoralf Prof. Dr. (2) Rajewsky, Klaus Prof. Dr. (3) Rajewsky, Nikolaus Prof. Dr. (1) Sander, Maike Prof. Dr. (2) Spuler, Simone Prof. (1) Stein, Ulrike Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (3) Wanker, Erich Prof. Dr. (4) Willnow, Thomas Prof. Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (8) 1992 (4) 1993 (7) 1994 (5) (-) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2001 (5) 2002 (5) 2003 (9) 2005 (10) 2006 (1) 2007 (6) 2008 (6) 2010 (10) 2011 (11) 2012 (9) 2013 (17) 2014 (12) 2015 (13) 2016 (17) 2017 (16) 2018 (15) 2019 (15) 2020 (9) 2021 (16) 2022 (26) 2023 (16) 2024 (23) Molecular Immunology and Gene Therapy (8) 8 Results: Active Filter: Blankenstein, Thomas Prof. Dr.1995 Sort: Result score Newest to oldest Oldest to newest January 01, 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling January 01, 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein January 01, 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu January 01, 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein January 01, 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein January 01, 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu
January 01, 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein
January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
January 01, 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
January 01, 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
January 01, 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
January 01, 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein
January 01, 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu